Home

Monte Rosa Therapeutics, Inc. - Common Stock (GLUE)

4.9500
-0.1100 (-2.17%)
NASDAQ · Last Trade: Apr 28th, 10:27 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Novartis Partner Monte Rosa Therapeutics Touts Positive Data From Early-Stage Study Of Investigational Drug Candidate For Immune-Mediated Disordersbenzinga.com
Monte Rosa's MRT-6160 shows promising Phase 1 results, with Novartis backing its development in a deal that could reach $2.1B in milestone payments.
Via Benzinga · March 20, 2025
Earnings Scheduled For March 20, 2025benzinga.com
Via Benzinga · March 20, 2025
Monte Rosa Therapeutics: Q4 Earnings Insightsbenzinga.com
Via Benzinga · March 14, 2024
Monte Rosa Therapeutics: Q3 Earnings Insightsbenzinga.com
Via Benzinga · November 9, 2023
Monte Rosa Stock Doubles — Up 127% — On A Massive Deal With Novartisinvestors.com
The companies will collaborate on a molecular glue degrader, a potential treatment for autoimmune diseases.
Via Investor's Business Daily · October 28, 2024
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · October 28, 2024
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Mondaybenzinga.com
Via Benzinga · October 28, 2024
Why Is Monte Rosa Therapeutics Stock Surging On Monday?benzinga.com
Monte Rosa Therapeutics stock rises as it announces a global licensing deal with Novartis to advance MRT-6160 for immune conditions.
Via Benzinga · October 28, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 28, 2024
GLUE Stock Earnings: Monte Rosa Therapeutics Beats EPS, Beats Revenue for Q2 2024investorplace.com
GLUE stock results show that Monte Rosa Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 8, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 16, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · May 15, 2024
GLUE Stock Earnings: Monte Rosa Therapeutics Beats EPS, Misses Revenue for Q1 2024investorplace.com
GLUE stock results show that Monte Rosa Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · March 26, 2024
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.
Via Benzinga · March 26, 2024
GLUE Stock Earnings: Monte Rosa Therapeutics Misses EPS for Q4 2023investorplace.com
GLUE stock results show that Monte Rosa Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 14, 2024
Monte Rosa Therapeutics' AI And Machine Learning Platform Is Adding Significant Value Creation in Cancer Research: Analystbenzinga.com
Wedbush initiates coverage on Monte Rosa Therapeutics. With differentiated lead programs and AI-driven QuEEN platform, the company shows strong potential for value creation.
Via Benzinga · February 15, 2024
3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Streetfool.com
Analysts have high hopes for these three innovation companies in 2024.
Via The Motley Fool · January 16, 2024
Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesdaybenzinga.com
U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session.
Via Benzinga · January 10, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 14, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · December 13, 2023
Crude Oil Moves Lower; Bank of America Profit Beats Expectationsbenzinga.com
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.09% to 33,954.39 while the NASDAQ fell 0.37% to 13,517.59. The S&P 500 also fell, dropping, 0.10% to 4,369.41.
Via Benzinga · October 17, 2023
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.
Via Benzinga · October 17, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · October 17, 2023
Dow Surges 100 Points; Goldman Sachs Posts Upbeat Earningsbenzinga.com
U.S. stocks traded mostly higher midway through trading, with the Dow Jones falling gaining around 100 points on Tuesday. The Dow traded up 0.31% to 34,090.15 while the NASDAQ fell 0.05% to 13,560.52. The S&P 500 also rose, gaining, 0.25% to 4,384.43.
Via Benzinga · October 17, 2023